Development of a LC-MS/MS-based method for determining metolazone concentrations in human plasma: Application to a pharmacokinetic study

Journal of Food and Drug Analysis

Volumn 21, Issue 2, 2013, Pages 154-159

  Chen, Yen An ^a,b   Hsu, Kuang Yang ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Protech Pharmaservices Corporation   (Taiwan)

Author keywords

Liquid chromatography; Mass spectrometry; Metolazone; Pharmacokinetic study

Indexed keywords

METOLAZONE; ZALEPLON;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG RETENTION; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

EID: 84881459227     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2013.05.004     Document Type: Article

References (12)

1. Winchester JF1 Kellett RJ, Boddy K, et al. Metolazone and bendroflumethiazide in hypertension: physiologic and metabolic observations. Clin Pharmacol Ther 1980;28:611-8. (Pubitemid 11254160)
2. Moser M. Low-dose diuretic therapy for hypertension. Clin Ther 1986;8:554-62. (Pubitemid 16014063)
3. Eades SK, Christensen ML. The clinical pharmacology of loop diuretics in the pediatric patient. Pediatr Nephrol 1998;12:603-16. (Pubitemid 28408236)
4. Tilstone WJ, Dargie H, Dargie EN, et al. Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure. Clin Pharmacol Ther 1974;16:322-9.
5. Curry CL, Janda SM, Harris R, et al. Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertension. Clin Ther 1986;9:47-62. (Pubitemid 17009355)
6. Brodie RR, Chasseaud LF, Walmsley LM. Determination of the diuretic agent metolazone in plasma by high-performance liquid chromatography. J Chromatogr 1981;226:526-32. (Pubitemid 12132028)
7. Vose CW, Muirhead DC, Evans GL, et al. Quantitation of metolazone in plasma and urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1981;222:311-5. (Pubitemid 11103103)
8. Marone C, Muggli F, Lahn W, et al. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man. Eur J Clin Invest 1985;15:253-7. (Pubitemid 16238174)
9. Farthing D, Sica DA, Fakhry I, et al. Novel high-performance liquid chromatographic method using solid-phase on-line elution for determination of metolazone in plasma and whole blood. J Chromatogr B Biomed Appl 1994;653:171-6. (Pubitemid 24085056)
10. Wei G, Xiao S, Liu C. Determination of metolazone in human blood by liquid chromatography with electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007;845:169-73. (Pubitemid 44839297)
11. Roy SMN, Mangaonkar KV, Yetal SM, et al. LC-MS-MS method for determination of metolazone in human plasma. E-J Chem 2008;5:634-40.
12. Jia Y, Zhang Y, Wang C, et al. An improved LC-MS/MS method for quantitative determination of metolazone in human plasma and its application to a pharmacokinetic study. Biomed Chromatogr 2011;25:1138-43.